PM360

JULY 13, 2023

During the COVID-19 pandemic, we saw healthcare organizations spend and scramble to implement numerous virtual care point solutions. The global healthcare IT market was valued at $280.3 billion in 2020 and is expected to reach $381.7 billion by 2025, growing at a compound annual growth rate of 6.7%. fitness trackers).

Healthcare 98

Healthcare Healthcare Consulting Healthcare Provider 98

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

Government 59

Government Specialization Physicians Education 59

European Pharmaceutical Review

NOVEMBER 8, 2022

Under two other pending bills – House of Representatives Bill 2883, titled Stop Stalling Access to Affordable Medications, and Senate Bill 1425, titled Stop STALLING 4 Act – it would be unfair competition to submit an “objectively baseless petition” to the FDA in an attempt to interfere with a competitor’s application to market a drug.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

Vodori

MAY 27, 2022

The pandemic has shaken the pharma sales channel and required companies to rethink their digital patient and HCP marketing strategies. A study from late 2020 says the pandemic accelerated pharma’s digital transformation two years in a two-month span. Today, audiences are expecting strong digital and video content.

Management 52

Management Healthcare Provider Sales Healthcare 52

Rep-Lite

OCTOBER 26, 2023

They seek fresh challenges that stimulate their intellectual curiosity and provide a new perspective on the healthcare industry. However, in 2020, 62% of nurses report feeling burned out. They work with the patient, their families, and a healthcare provider or physical therapist to create comprehensive care plans.

Education 52

Education Healthcare Healthcare Recruitment 52

Salesforce

JANUARY 26, 2020

In 2020, the pharmaceutical industry continues its transition to value-based outcomes and a focus on gathering more real-world evidence. Leaders will center strategies on outcomes by conveying the value of medications to providers, forging strong partnerships with payers, and establishing direct patient relationships.

Pharmaceutical 52

Pharmaceutical Customer Relationship Management CRM Medical 52

Pharmaceutical Technology

SEPTEMBER 26, 2022

Strong competition limits Sandoz's growth. Sandoz has faced and may in the future face strong competition from other generic and biosimilar pharmaceutical companies, which aggressively compete for market share, including through significant price competition. The company had revenues of $9.6bn both in 2020 and last year.

Competition 64

Competition Manufacturing Marketing Distribution 64

Cadensee

JULY 26, 2021

We established a wholly owned subsidiary in the US and we have an office in San Diego with sales and marketing personnel. Which oftentimes, the sales are running very fast and the operations isn't there to support it. Could you walk us through the differences between or the different approaches in terms of the sales strategy?

Retail 52

Retail Marketing Doctors Food 52

Pharma Marketing Network

JUNE 8, 2020

As long as I’ve been in this business marketers have kind of been obsessed over this idea of attribution, understanding which touches are working, where the shift is occurring in the funnel through any kind of a sales process to understand when somebody goes from stage to stage, what was the mechanism that created that impact.

Marketing 40

Marketing Pharma Healthcare Healthcare 40

Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. Anti-obesity therapeutic landscape. million in Q3.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. Anti-obesity therapeutic landscape. million in Q3.

Medical 98

Medical Manufacturing Insurance Side effects 98